Complete prevalence of malignant primary brain tumors registry data in the United States compared with other common cancers, 2010

Neuro-Oncology

Volumn 19, Issue 5, 2017, Pages 726-735

  Zhang, Adah S ^a,b   Ostrom, Quinn T ^a,c   Kruchko, Carol ^a   Rogers, Lisa ^a,d   Peereboom, David M ^a,e   Barnholtz Sloan, Jill S ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SANDIA NATIONAL LABORATORIES   (United States)

^c Central Brain Tumor Registry of the United States (CBTRUS)   (United States)

^d UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Brain tumors; Epidemiology; Glioblastoma; Glioma; Prevalence

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BRAIN TUMOR; BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; CHILD; CHILDHOOD LEUKEMIA; CUTANEOUS MELANOMA; FEMALE; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PILOCYTIC ASTROCYTOMA; PREVALENCE; SURVIVAL RATE; UNITED STATES; AGE; AGED; COMPARATIVE STUDY; INFANT; MIDDLE AGED; NEOPLASM; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; REGISTER; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; PROGNOSIS; REGISTRIES; SEER PROGRAM; SURVIVAL RATE; UNITED STATES; YOUNG ADULT;

EID: 85019105022     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/now252     Document Type: Article

References (24)

1. Surveillance Epidemiology and End Results Program. Public Law 107-260. training.seer.cancer.gov/brain/non-malignant/history/public.html. Accessed November 14, 2016.
2. Ostrom Q T, Gittleman H, Liao P, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro Oncol. 2014;16(s4):iv1-iv63.
3. Ostrom Q T, Gittleman H, Fulop J, et al. CBTRUS statistical report: pri-mary brain and central nervous system tumors diagnosed in the United States in 2008-2012. Neuro Oncol. 2015;17(Suppl 4):iv1-iv62.
4. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classifca-tion of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97-109.
5. Centers for Disease Control and Prevention. Data Collection of Primary Central Nervous System Numbers National Program of Cancer Registries Training Materials. Atlanta, Georgia: Department of Health and Human Services, Centers for Disease Control and Prevention;2004.
6. Capocaccia R, De Angelis R. Estimating the completeness of prevalence based on cancer registry data. Stat Med. 1997;16(4):425-440.
7. Howlader N, Noone AM, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2010, Based On November 2012 SEER Data Submission, Posted to the SEER Web Site, April 2013. Bethesda, MD: National Cancer Institute;2013.
8. National Cancer Institute. Overview of the SEER Program. http://seer. cancer.gov/about/overview.html. Accessed November 14, 2016.
9. Surveillance Epidemiology and End (SEER) Program. SEER∗Stat Database: Incidence-SEER 9 Regs Research Data, Nov 2014 Sub (1973-2012)-Linked To County Attributes-Total U.S., 1969-2013 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2015, based on the November 2014 submission.
10. Surveillance Epidemiology and End Results (SEER) Program. SEER∗Stat Database: Incidence-SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2015 Sub (1973-2013 varying)-Linked To County Attributes-Total U.S., 1969-2014 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2016, based on the November 2015 submission.
11. Surveillance Epidemiology and End Results (SEER) Program. SEER∗Stat software version 8.2.1; www.seer.cancer.gov/seerstat, 2015, Accessed November 14, 2016.
12. Surveillance Research Program. Complete Prevalence (ComPrev) Software version 2.0, https://surveillance.cancer.gov/comprev/, 2015. Accessed November 14, 2016.
13. Verdecchia A, De Angelis G, Capocaccia R. Estimation and projections of cancer prevalence from cancer registry data. Stat Med. 2002;21(22):3511-3526.
14. Wickham H. ggplot2: elegant graphics for data analysis. Springer Science & Business Media, 2009.
15. R Core Team. R: A language and environment for statistical computing. http://www.R-project.org/. Accessed November 14, 2016.
16. Davis FG, Kupelian V, Freels S, et al. Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. Neuro Oncol. 2001;3(3):152-158.
17. Porter KR, McCarthy BJ, Freels S, et al. Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology. Neuro Oncol. 2010;12(6):520-527.
18. Ostrom QT, Gittleman H, de Blank PM, et al. American brain tumor association adolescent and young adult primary brain and central nervous system tumors diagnosed in the United States in 2008-2012. Neuro Oncol. 2016;18(Suppl 1):i1-i50.
19. Stupp R, Mason WP, van den Bent MJ, et al.; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblas-toma. N Engl J Med. 2005;352(10):987-996.
20. Benign Brain Tumor Cancer Registries Amendment Act. 2002; http://www.gpo.gov/fdsys/pkg/PLAW-107publ260/pdf/PLAW-107publ260. pdf. Accessed November 14, 2016.
21. van Alkemade H, de Leau M, Dieleman EM, et al. Impaired survival and long-term neurological problems in benign meningioma. Neuro Oncol. 2012;14(5):658-666.
22. Gittleman HR, Ostrom QT, Rouse CD, et al. Trends in central nervous system tumor incidence relative to other common cancers in adults, adolescents, and children in the United States, 2000 to 2010. Cancer. 2015;121(1):102-112.
23. Louis DN, Ohgaki H, Wiestler OD, et al, eds. WHO Classifcation of Tumours of the Central Nervous System. Lyon, France: International Agency for Research on Cancer; 2016.
24. Ostrom QT, Gittleman H, Kruchko C, et al. Completeness of required site-specifc factors for brain and CNS tumors in the Surveillance, Epidemiology and End Results (SEER) 18 database (2004-2012, varying). J Neurooncol. 2016;130(1): 31-42.